版本:
中国

BRIEF-Corvus Pharmaceuticals and Monash University enter into exclusive license agreement

May 9 Corvus Pharmaceuticals Inc:

* Corvus Pharmaceuticals and Monash University enter into exclusive license agreement for novel immuno-oncology program

* Corvus Pharmaceuticals - licensed global rights to undisclosed novel immuno-oncology program, which includes lead product candidate, from Monash University Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐